Top Markets
Coin of the day
Canton Strategic Holdings Inc Canton Strategic Holdings Inc

Canton Strategic Holdings Inc

CNTN
Classifica tra le azioni #19011
Canton Strategic Holdings Inc., which was formerly known as Tharimmune, Inc.... Canton Strategic Holdings Inc., which was formerly known as Tharimmune, Inc. until its name change in February 2026, focuses on two primary areas. The company is committed to promoting the institutional integration of blockchain technology and fostering the digitization of financial markets, primarily by leveraging Canton Coin and offering support to the Canton network. In addition to its blockchain initiatives, the company is also deeply involved in pharmaceutical research and development. Its pipeline includes GV104, a buccal film technology designed to address respiratory and/or nervous system depression in military personnel and chemical incident responders, which has already finished its Phase 1 trial. Another significant project is GV023, an oral version of infliximab, engineered to resolve the key inconvenience of the standard intravenous treatment by eliminating the need for recurring infusions. Established in 2017, Canton Strategic Holdings Inc. is headquartered in Red Bank, New Jersey.
Prezzo delle azioni
$2.35
Capitalizzazione di mercato
$180.85M
Variazione (1 giorno)
1.52%
Variazione (1 anno)
-61.62%
Paese
US
Scambia Canton Strategic Holdings Inc (CNTN)

Categoria

Rapporto P/B per Canton Strategic Holdings Inc (CNTN)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Canton Strategic Holdings Inc, il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Canton Strategic Holdings Inc da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
6.3419 -
US
6.2413 -
NL
3.7087 -
US
2.5054 -
AU
- -
CH